Use molecular methods distribution epitopes topoisomerase sera scleroderma patients initial molecular characterization autoimmune response DNA topoisomerase topo Sera patients scleroderma healthy control subjects subcloned portions topo Twenty-three sera independent epitopes molecule anti-topo non-organ-specific autoantibodies date polyclonal multifocal cloned protein suitable sensitive early detection anti-topo clinical setting 